Alternatives
Alternatives to Clariscan 5653.5 mg/15 mL injection
2 other presentations of Gadoterate 5653.5 mg/15 mL injection
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Gadoterate), strength (5653.5 mg/15 mL) and dosage form (injection) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Clariscan 5653.5 mg/15 mL injectionThis pageIntravenous | GE Healthcare | US FDA | 10 vials of 15 mL, 10 syringes of 15 mL | Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Should solidification occur in the vial because of exposure to the cold, bring Clariscan to room temperature before use. If allowed to stand at room temperature for a minimum of 90 minutes, Clariscan should return to a clear, colorless to yellow solution. | On request | — | Available on request |
| Dotarem 5653.5 mg/15 mL injectionIntravenous | Guerbet | US FDA | 10 vials of 15 mL, 10 vials of 15 mL | Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Should solidification occur in the vial because of exposure to the cold, bring DOTAREM to room temperature before use. If allowed to stand at room temperature for a minimum of 90 minutes, DOTAREM should return to a clear, colorless to yellow solution. | On request | — | Available on request |
| Gadoterate 5653.5 mg/15 mL injectionIntravenous | — | US FDA | 10 cartons of 15 mL, 10 vials of 15 mL | Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Should solidification occur in the vial because of exposure to the cold, Gadoterate Meglumine Injection, USP should be brought to room temperature before use. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Clariscan 5653.5 mg/15 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.